ChromaDex banner
Home Search

dementia - search results

If you're not happy with the results, please do another search
Longevity supplement Mitocholine addresses “brain energy gap” to counteract development of metabolic syndrome and impede onset of dementia.
Mitochondria

New Longevity supplement targets cognitive decline

Danny Sullivan - 0
Oxford University targets arterial stiffening earlier in a person’s lifespan for age-related cognitive benefit and dementia delay.
Tissue/Organ

Study linking heart health to brain health could delay dementia

Eleanor Garth - 0
As the world enters the new year with a vaccine and an increased focus on geroprotection there’s much to look forward to.
Investment

Longevity companies to watch in 2021

Margaretta Colangelo - 0
Although age-related cognitive decline is commonly associated with aging, superagers retain exceptional memory performance.
Wellness

Rise of the superagers – sharp minds and youthful cognition

Christos Evangelou - 0
Development

A year in Longevity: progress perspectives

Eleanor Garth - 0
Epigenetic aging clock DeepMAge has 3-year error margin and could be the most accurate DNA methylation clock to date.
Development

Deep Longevity reveals highly-accurate aging clock

Eleanor Garth - 0
Rubedo Life Sciences closes $12m seed round for proprietary drug discovery platform that targets senolytics.
Investment

Silicon Valley is waking up to Longevity and senolytics

Eleanor Garth - 0
Incorporating bio.markers into the research definition of Alzheimer's disease should lead to delayed progression
Clinical trials

Defining Alzheimer’s by biomarkers could improve clinical trials

Eleanor Garth - 0
Keystone Bio seeks funding as it gears up for clinical trials of therapeutic targeting the “keystone pathogen” of chronic inflammation.
Clinical trials

Targeting inflammaging: the hidden “inflammapath” inside us

Danny Sullivan - 0
Dr David Karow
Diagnosis

The rise of precision diagnostics and therapeutics

Danny Sullivan - 0
123...9Page 1 of 9

LATEST ARTICLES

Oisín’s therapy has been shown to efficiently eliminate senescent cells body-wide in multiple animal models and has demonstrated therapeutic benefit in both disease burden and lifespan.
Cellular

Promising restorative therapy potentially 5 years away

Margaretta Colangelo - 0
Oisín Biotech on targeting senescence and senolytic gene therapy.   “The ultimate goal is to eliminate unnecessary suffering. I think that everyone who believes in the mission...
The Death of Death seeks to disrupt the paradigm of accepting aging and death as inevitable consequences.

Longevity Escape Velocity within 10 years?

Wellness
Stanford study finds that blocking certain interactions on immune cells reverses age-related mental decline in older mice. Photography by Steve Fisch

“Adjust the immune system… de-age the brain”

Cellular
A long-awaited Deep-SeSMo AI approach can now be implemented in screening for anti-senescence cell drug candidates.

AI to quantify senescent cell counts

Development
TISSUE/ORGAN | NANOTECH | SENESCENCE | CELLULAR | DRUGS | AI | NEURAL | AGETECH | INVESTMENT

LONGEVITY MARKET | ABOUT US | MY ACCOUNT | SHARE YOUR NEWS | CONTACT US

PRIVACY POLICY | COOKIE POLICY | TERMS AND CONDITIONS | COPYRIGHT POLICY

© Copyright 2020 PERGALI Limited. All rights reserved. PERGALI, Longevity.Technology and their associated logos are trademarks of PERGALI Limited and are the subject of trademark applications or registrations in various countries around the world. All other trademarks are the property of their respective owners. All PERGALI products and services are subject to continuous development. We reserve the right to alter technical specifications without prior notice.